BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
22.39
+0.13 (0.58%)
At close: May 28, 2025, 4:00 PM
22.35
-0.04 (-0.18%)
After-hours: May 28, 2025, 4:10 PM EDT
BioLife Solutions Market Cap
BioLife Solutions has a market cap or net worth of $1.06 billion as of May 28, 2025. Its market cap has increased by 30.52% in one year.
Market Cap
1.06B
Enterprise Value
984.21M
1-Year Change
30.52%
Ranking
Category
Stock Price
$22.39
Market Cap Chart
Since December 1, 1998, BioLife Solutions's market cap has increased from $4.30M to $1.06B, an increase of 24,664.99%. That is a compound annual growth rate of 23.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 1.06B | -12.08% |
| Dec 31, 2024 | 1.20B | 68.30% |
| Dec 29, 2023 | 715.50M | -8.07% |
| Dec 30, 2022 | 778.30M | -49.86% |
| Dec 31, 2021 | 1.55B | 18.87% |
| Dec 31, 2020 | 1.31B | 294.62% |
| Dec 31, 2019 | 330.90M | 48.65% |
| Dec 31, 2018 | 222.60M | 172.13% |
| Dec 29, 2017 | 81.80M | 295.17% |
| Dec 30, 2016 | 20.70M | -22.18% |
| Dec 31, 2015 | 26.60M | 34.34% |
| Dec 31, 2014 | 19.80M | -53.08% |
| Dec 31, 2013 | 42.20M | 78.06% |
| Dec 31, 2012 | 23.70M | 577.14% |
| Dec 30, 2011 | 3.50M | -16.67% |
| Dec 31, 2010 | 4.20M | -45.45% |
| Dec 31, 2009 | 7.70M | 266.67% |
| Dec 31, 2008 | 2.10M | -50.00% |
| Dec 31, 2007 | 4.20M | -12.50% |
| Dec 29, 2006 | 4.80M | 220.00% |
| Dec 30, 2005 | 1.50M | 36.36% |
| Dec 31, 2004 | 1.10M | -21.43% |
| Dec 31, 2003 | 1.40M | -6.67% |
| Dec 31, 2002 | 1.50M | -42.31% |
| Dec 31, 2001 | 2.60M | -57.38% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 643.90B |
| Johnson & Johnson | 365.99B |
| AbbVie | 324.59B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 271.27B |
| Abbott Laboratories | 230.48B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |